Company Management

Shift Pharmaceuticals

Pharmaceutical Manufacturing Overland Park, Kansas, United States 5 employees

Employees: 5
Contacts: 3
Emails: 3
Phones: 1

www.shiftpharmaceuticals.com LinkedIn

Shift Pharmaceuticals Overview

Headquarters: Overland Park, Kansas, United States
Phone Number: Available in AeroLeads
Website: www.shiftpharmaceuticals.com
Industry: Pharmaceutical Manufacturing
Employees: 5
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

New Minas

About Shift Pharmaceuticals

Shift Pharmaceuticals is developing Antisense Oligonucleotides as drug candidates for a variety of genetic disorders, including Charcot Marie Tooth Syndrome (CMT1A) and Spinal Muscular Atrophy (SMA). Rather than alleviating certain disease side effects, these molecules “SHIFT” the body’s natural protein production back into alignment effectively addressing the core cause of the disease. We are supported with funding from the NIH, DoD, CMT Research Foundation, and Gwendolyn Strong Foundation.

Shift Pharmaceuticals Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage
Phone contacts: 1; 33.3% coverage

Shift Pharmaceuticals Org Chart

Sample employees and titles

Name	Title	Location	Contact
Steve O'connor	CEO Shift Pharmaceuticals at Shift	Kansas City Metropolitan Area, United States	Email Phone
Chris Lorson	Associate Vice Chancellor for Research	Columbia, Missouri, United States	Email
Paul Morcos	Director of Research and Development	Corvallis, Oregon, United States	Email